Sugammadex in patients with myasthenia gravis.
De Boer
H D
HD
Martini General Hospital, Groningen, Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands E-mail: HD.de.Boer@mzh.nl.
Van Egmond
J
J
Martini General Hospital, Groningen, Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands E-mail: HD.de.Boer@mzh.nl.
Driessen
J J
JJ
Martini General Hospital, Groningen, Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands E-mail: HD.de.Boer@mzh.nl.
Booij
L H J D
LHJD
Martini General Hospital, Groningen, Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands E-mail: HD.de.Boer@mzh.nl.
D000732:Androstanols / Q000037:antagonists & inhibitors*; D006801:Humans; D009157:Myasthenia Gravis / Q000503:physiopathology*; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D011182:Postoperative Care / Q000379:methods; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000494:pharmacology*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium